Sun Pharma Advanced Research is looking good: Sandeep Wagle, APTART Technical Advisory Services

Sandeep Wagle, Founder & MD, APTART Technical Advisory Services, in a chat with ET Now talks about Sun Pharma Advanced Research and Piramal Healthcare.

What is your take on Sun Pharma Advanced Research and Piramal Healthcare?

SPARC is still looking good. If the market starts moving up, I would have first target of around 103 on SPARC and once that is broken, we can talk of 110-115. Piramal Healthcare has already moved up. I would refrain from getting into it at this level, possibly on a little bit of a decline, somewhere around 535-525 levels I will look at it. It is currently around 548. Trend remains positive.